RCMU
AGL icon

Rokos Capital Management (UK)’s Agilon Health AGL Stock Holding History

Rokos Capital Management (UK)’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-800
Closed -$789K – 103
2021
Q2 		$789K Buy
+800
New +$701K 0.02% 107

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Rokos Capital Management (UK)'s AGL Position: Q3 2021 in Review

Rokos Capital Management (UK) sold out of Agilon Health (AGL) in Q3 2021, closing a stake of 800 shares — an estimated $789K sold.

Rokos Capital Management (UK) first reported a position in AGL in Q2 2021 and held it in 1 quarter. The position peaked at $789K in Q2 2021. 102 funds tracked by Wall St. Rank hold AGL as of Q3 2021.

  • Rokos Capital Management (UK) reported no remaining Agilon Health position as of Q3 2021 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 800 Agilon Health shares in Q3 2021, an estimated $789K.
  • Rokos Capital Management (UK) first reported a position in Agilon Health in Q2 2021 and held it in 1 quarter.
  • Rokos Capital Management (UK)'s Agilon Health position peaked at $789K in Q2 2021.
  • 102 funds tracked by Wall St. Rank held Agilon Health as of Q3 2021.

Based on Rokos Capital Management (UK)'s 13F filing for Q3 2021, filed 15 Nov 2021.